Arcadia Biosciences, Inc.: which funds bought and sold
Institutions that bought and sold Arcadia Biosciences shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 8 institutions that filed 13F reports for both quarters added to or opened positions in Arcadia Biosciences, and 9 cut or closed them. Together they sold a net 138K shares, −39.5% on what they held at the start of the quarter. Active managers and hedge funds on our list were net sellers of 136K shares (−85.1%); index fund managers were net sellers of 20K shares (−34.5%). 8 opened a new position and 7 sold out entirely.
Bought, Q2 2026 8 institutions, 8 of them new holders Sold, Q2 2026 9 institutions, 7 of them sold out
Net change, all compared −138K shares (−39.5%)
Net change, active managers −136K shares (−85.1%), 1 bought, 1 sold
Buyers versus sellers
8 bought 6 9 sold
Active managers and hedge funds 1 bought · 1 sold · −136K
Index fund managers 0 bought · 2 sold · −20K
Other institutions 7 bought · 6 sold · +18K
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| HRT Financial LP | +88K New position | 88K | $60,000 |
| Citadel Advisors LLC Hedge fund | +24K New position | 24K | $16,120 |
| Virtu Financial LLC | +22K New position | 22K | $15,000 |
| Xtx Topco Ltd | +15K New position | 15K | $10,509 |
| Stonex Group Inc. | +14K New position | 14K | $11,259 |
| Jane Street Group, LLC | +10K New position | 10K | $6,957 |
| TD Waterhouse Canada Inc. | +70 New position | 70 | $50 |
| Caitong International Asset Management Co., Ltd | +1 New position | 1 | $1 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Citadel Advisors LLC Hedge fund | +24K New position | 24K | $16,120 |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Armistice Capital, LLC Hedge fund | −159K Sold out | 0 | — |
| Sabby Management, LLC | −115K Sold out | 0 | — |
| Geode Capital Management, LLC Index funds | −16K −49.2% | 16K | $10,957 |
| Susquehanna International Group, LLP | −13K Sold out | 0 | — |
| Vanguard Fiduciary Trust Co Index funds | −4,394 Sold out | 0 | — |
| Tower Research Capital LLC (TRC) | −3,940 Sold out | 0 | — |
| UBS Group AG | −772 −95.7% | 35 | $24 |
| Assetmark, Inc | −5 Sold out | 0 | — |
| Citigroup Inc | −1 Sold out | 0 | — |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Armistice Capital, LLC Hedge fund | −159K Sold out | 0 | — |
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| HRT Financial LP | 88K | $60,000 |
| Citadel Advisors LLCHedge fund | 24K | $16,120 |
| Virtu Financial LLC | 22K | $15,000 |
| Stonex Group Inc. | 14K | $11,259 |
| Xtx Topco Ltd | 15K | $10,509 |
| Jane Street Group, LLC | 10K | $6,957 |
| TD Waterhouse Canada Inc. | 70 | $50 |
| Caitong International Asset Management Co., Ltd | 1 | $1 |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| Armistice Capital, LLCHedge fund | 159K | $219,958 |
| Sabby Management, LLC | 115K | $158,085 |
| Susquehanna International Group, LLP | 13K | $17,407 |
| Vanguard Fiduciary Trust CoIndex funds | 4,394 | $6,064 |
| Tower Research Capital LLC (TRC) | 3,940 | $5,437 |
| Assetmark, Inc | 5 | $7 |
| Citigroup Inc | 1 | $1 |
Who holds the shares
- Institutions reporting
- 16
- Ten largest holders
- 99.9% of 13F-reported shares
- Index fund managers
- 17.9% of 13F-reported shares
- Active managers and hedge funds
- 11.2% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 1 | 1 | 1 | 1 | −136K | −85.1% |
| Index fund managers | 0 | 2 | 0 | 1 | −20K | −34.5% |
| Other institutions | 7 | 6 | 7 | 5 | +18K | +13.4% |
← Back to Arcadia Biosciences, Inc. · Insiders · Politicians